Acorda Therapeutics, Inc. Accumulated Other Comprehensive Income
Acorda Therapeutics, Inc. had Accumulated Other Comprehensive Income of $875.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-05-14
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $875.00K.
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.43M.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $717.00K.
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $880.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2024-03-31 | $875.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.43M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $717.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $880.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $719.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $628.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.09M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $738.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$568.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$1.02M 10-K · filed 2023-03-15 | |
| 2021-09-30 | -$1.56M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$1.83M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$1.73M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | -$2.80M 10-K · filed 2022-03-18 | |
| 2020-09-30 | -$2.29M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$1.22M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$819.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$1.17M 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$636.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.62M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.38M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $2.81M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $4.11M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $4.80M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $9.31M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $6.86M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $6.94M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$329.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$10.50M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$12.90M 10-K/A · filed 2018-03-09 | |
| 2016-09-30 | -$3.62M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | -$4.71M 10-Q · filed 2016-08-04 | |
| 2015-12-31 | -$119.00K 10-K · filed 2017-02-27 | |
| 2015-09-30 | -$43.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$60.00K 10-Q · filed 2015-08-07 | |
| 2015-03-31 | -$91.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$74.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $166.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $96.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $82.00K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $37.00K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $98.00K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $54.00K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $83.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $62.00K 10-K · filed 2014-03-03 | |
| 2012-09-30 | $69.00K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | -$39.00K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | -$34.00K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $66.00K 10-K · filed 2013-02-28 | |
| 2011-09-30 | $69.00K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $112.00K 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $40.00K 10-Q · filed 2011-05-09 | |
| 2010-12-31 | -$12.00K 10-K · filed 2012-02-28 | -$12.58K 10-K · filed 2011-03-01 |
| 2010-09-30 | $22.14K 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $9.31K 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $108.61K 10-K · filed 2011-03-01 |